文献速递腹部MR

比较非增强MRI与钆塞酸二钠简化MRI在初诊肝细胞癌患者中的诊断效能:肝细胞癌监测的模拟研究

Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.
PubMed 文献 · Eur Radiol · 2020-03-12

本研究纳入140例初诊肝细胞癌患者(173个病灶,均在米兰标准内)及123例无肝细胞癌对照,由两名放射科医师独立评估非增强MRI组套与钆塞酸二钠简化MRI组套。结果显示两种方案在患者水平和病灶水平的敏感度与特异度均无显著差异,作者认为两者对早期肝细胞癌的诊断效能相当。

要点

  • 非增强MRI与钆塞酸二钠简化MRI对早期肝细胞癌的诊断效能相当。
  • 两种方案在患者水平和病灶水平的敏感度与特异度均无显著差异。
  • 采用简化聚焦的MRI方案可能改善高危患者肝细胞癌监测的结局。

核心结论

  • 非增强MRI与钆塞酸二钠简化MRI对早期肝细胞癌患者的诊断效能相当。
  • 两种方案对早期肝细胞癌均显示较高的敏感度和特异度。

研究设计与样本

  • 研究纳入2015至2016年间140例新诊断肝细胞癌患者(173个病灶,均在米兰标准内)及同期123例无肝细胞癌的监测对照。
  • 两名放射科医师独立评估两套MRI:非增强组套包括T2 FSE/ssFSE、T1同相位与反相位、DWI及ADC图;简化组套包括T2 FSE/ssFSE、钆塞酸二钠注射后20分钟肝胆期图像、DWI及ADC图。

诊断标准与关键数值

  • 患者水平:阅片者1非增强组套敏感度85.7%、简化组套90.0%;阅片者2分别为86.4%和89.3%。
  • 患者水平:两名阅片者对两种组套的特异度均为92.7%。
  • 病灶水平:阅片者1非增强组套敏感度81.5%、简化组套84.4%;阅片者2分别为79.8%和84.4%,均无显著差异。

临床应用与阅片要点

  • 作者认为,采用简化聚焦的MRI方案可能改善高危患者肝细胞癌监测的结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study was conducted in order to compare the diagnostic performance of noncontrast and abbreviated MRI using gadoxetic acid for detecting hepatocellular carcinoma (HCC) in initially diagnosed HCC patients.

METHODS: We identified 140 consecutive patients with newly diagnosed HCC (173 HCCs) within the Milan criteria, who underwent liver MRI using gadoxetic acid between 2015 and 2016. One hundred twenty-three consecutive patients without HCC who underwent liver MRI in the same period for HCC surveillance were enrolled for the control group. Two radiologists independently reviewed two MRI sets: a noncontrast set and an abbreviated set. The noncontrast set consists of T2 FSE/ssFSE, T1 in- and out-of-phase image, DWI, and the ADC map. The abbreviated set consists of T2 FSE/ssFSE, hepatobiliary phase image 20 min after gadoxetic acid injection, DWI, and the ADC map.

RESULTS: In a per-patient analysis, sensitivity of reviewer 1 for noncontrast and abbreviated sets was 85.7 and 90.0%, respectively. The specificity for both noncontrast and abbreviated sets was 92.7%. For reviewer 2, sensitivity of noncontrast and abbreviated sets was 86.4 and 89.3%, respectively. Per-patient specificity of reviewer 2 was 92.7% for both noncontrast and abbreviated sets. The sensitivity and specificity of two image sets were not significantly different for both reviewers. The per-tumor sensitivity of noncontrast and abbreviated sets was 81.5 and 84.4% for reviewer 1, respectively, and 79.8 and 84.4% for reviewer 2, respectively. There was no significant difference.

CONCLUSION: Noncontrast and abbreviated MRI using gadoxetic acid showed comparable diagnostic performance for detecting patients with HCCs in the early stage.

KEY POINTS: • Diagnostic performance of noncontrast MRI and abbreviated MRI using gadoxetic acid for detecting HCCs is comparable in patients with HCCs in the early stage. • Noncontrast MRI and abbreviated MRI showed high sensitivity and specificity for detecting HCCs in the early stage. • Outcomes of surveillance for HCC in high-risk patients can be improved by adopting these simplified and focused MRI protocols.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Whang S, Choi MH, Choi JI, et al. Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas. Eur Radiol. 2020. PMID: 32166493. doi:10.1007/s00330-020-06754-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。